Home > News > Nucryst Looks to Zap Zits
March 10th, 2006
Nucryst Looks to Zap Zits
Jack Uldrich: Yesterday, Nucryst announced that it had been granted a new patent that covers the company’s poprietary nanocrystalline silver for treating acne.
Given the number of teenagers that still suffer from this vexing condition, the patent could prove to be very profitable for the company. In my estimation, however, this news alone is not enough to change my bearish opinion of Nucryst.
Arrowhead to Present at 2015 Barclays Global Healthcare Conference March 4th, 2015
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015
Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015